Search results
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 4 days agoThe trial involved about 11,400 patients aged 12 years ad older, half of whom were given mRNA-1283,...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 6 days agoA male doctor wearing a white N95 mask gives a vaccine to an older male patient wearing a white...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 4 days agoThe trial involved about 11,400 patients age 12 and older, half of whom were given mRNA-1283, the new vaccine, and half of whom were given Spikevax. "Today's ...
Moderna’s flu-COVID combo shot hits goal in late-stage trial
Detroit News· 7 days agotrial, bringing the company one step closer to a more convenient jab that could help combat vaccine...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 7 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo News· 3 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 6 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced ...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine
Fox Bangor· 7 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - The Boston Globe
The Boston Globe· 7 days agotrial, bringing the company one step closer to a more convenient jab that could help combat vaccine...